Baxter Urges Fed. Circ. Not To Reopen Fresenius Battle

Law360, Washington (March 4, 2013, 6:44 PM EST) -- Baxter International Inc. blasted rival medical device maker Fresenius USA Inc.'s attempt to gain a new damages trial in their patent dispute over dialysis machine technology in the Federal Circuit on Monday, saying the request is unwarranted, as the only issue left before the courts is to set ongoing royalties.

According to Baxter, a California federal court has already issued final judgment in the case on a variety of issues, including validity and damages, and has ordered Fresenius to pay $23.5 million in damages and royalties...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.